Aethlon Medical Inc financial data

Symbol
AEMD on Nasdaq
Location
11555 Sorrento Valley Road, Suite 203, San Diego, CA
State of incorporation
NV
Fiscal year end
March 31
Former names
BISHOP EQUITIES INC (to 3/13/2000)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 444 % -47.9%
Debt-to-equity 32.5 % +80.3%
Return On Equity -71.7 % -46.6%
Return On Assets -107 % -66.4%
Operating Margin -6.92K % -538%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.9M shares -43.9%
Common Stock, Shares, Outstanding 13.9M shares -43.9%
Entity Public Float 5.5M USD -58.3%
Common Stock, Value, Issued 13.9K USD -43.9%
Weighted Average Number of Shares Outstanding, Basic 7.46M shares +207%
Weighted Average Number of Shares Outstanding, Diluted 7.46M shares +207%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 162K USD -79.5%
Revenue from Contract with Customer, Excluding Assessed Tax 574K USD +95.2%
Research and Development Expense 2.26M USD -12.1%
General and Administrative Expense 3.35M USD -29.6%
Operating Income (Loss) -11.8M USD +4.45%
Net Income (Loss) Attributable to Parent -11.5M USD +7.33%
Earnings Per Share, Basic -3.85 USD/shares +45.2%
Earnings Per Share, Diluted -3.85 USD/shares +45.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.07M USD -29.7%
Cash, Cash Equivalents, and Short-term Investments 250K USD
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 9.55M USD -28.2%
Property, Plant and Equipment, Net 929K USD -27.6%
Operating Lease, Right-of-Use Asset 814K USD -25.1%
Assets 11.4M USD -27.8%
Accounts Payable, Current 1.07M USD +26.5%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 2.13M USD +16.9%
Operating Lease, Liability, Noncurrent 574K USD -34%
Liabilities 2.7M USD +0.41%
Accumulated Other Comprehensive Income (Loss), Net of Tax -7.77K USD -8.94%
Retained Earnings (Accumulated Deficit) -157M USD -7.89%
Stockholders' Equity Attributable to Parent 8.71M USD -33.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 5.77M USD -61.7%
Liabilities and Equity 11.4M USD -27.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.75M USD +29.6%
Net Cash Provided by (Used in) Financing Activities 5.38M USD +399%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 13.9M shares -43.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.63M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.16M USD -29.5%
Deferred Tax Assets, Valuation Allowance 33.3M USD +10.8%
Deferred Tax Assets, Gross 33.3M USD +10.8%
Operating Lease, Liability 870K USD
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1M USD -23.9%
Property, Plant and Equipment, Gross 1.11M USD +12.4%
Operating Lease, Liability, Current 296K USD +7.86%
Lessee, Operating Lease, Liability, to be Paid, Year Two 333K USD +2.98%
Lessee, Operating Lease, Liability, to be Paid, Year One 324K USD +2.96%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 60.3K USD -43.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 343K USD +2.97%
Deferred Tax Assets, Operating Loss Carryforwards 26.9M USD +11.5%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 343K USD
Additional Paid in Capital 166M USD +4.48%
Depreciation, Depletion and Amortization 86.1K USD -4.72%
Deferred Tax Assets, Net of Valuation Allowance 0 USD